6-KThe Wire
HUTCHMED (China) Ltd files 6-K
Filed May 22, 2026 · 1mo ago · Accession 0001648257-26-000035
Plain English
Hutchmed (China) Limited announced that clinical data for its drug candidate, savolitinib, will be presented at the 2026 ASCO Annual Meeting. This filing does not contain financial results.
Filing details
- Company
- HUTCHMED (China) Ltd
- Ticker
- HCM
- CIK
- 1648257
- Form type
- 6-K
- Filing date
- May 22, 2026
- Report date
- May 22, 2026
- Document
- hcm-20260522x6k.htm
- Size
- 84 KB